Skip to main content

Advertisement

Log in

Body mass index increases the risk of breast cancer-related lymphedema at 6–18 months after surgery: a retrospective study

  • Research
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer-related lymphedema (BCRL) is an incurable complication occurring after breast cancer treatment. The influence of obesity/overweight on the development of BCRL at different points after surgery was seldom verified. We aimed to determine the cut-off BMI/weight value associated with an increased risk of BCRL at different postoperative time in Chinese breast cancer survivors.

Methods

Patients who underwent breast surgery plus axillary lymph node dissection (ALND) were retrospectively evaluated. Disease and treatment characteristics of participants were collected. BCRL was diagnosed by circumference measurements. Univariate and multivariable logistic regression was used to assess the relationship of lymphedema risk with BMI/weight and other disease- and treatment-related factors.

Results

518 patients were included. Lymphedema occurred more frequently among breast cancer patients with preoperative BMI ≥ 25 kg/m2 (37.88%) than among those with preoperative BMI < 25 kg/m2(23.32%), with significant differences at 6–12 and 12–18 months after surgery (χ2 = 23.183, P = 0.000; χ2 = 5.279, P = 0.022). By multivariable logistics analysis, preoperative BMI ≥ 30 kg/m2 presented a significantly greater risk of lymphedema than a preoperative BMI < 25 kg/m2 (OR [95% CI] = 2.928 [1.565, 5.480]). Other factors, including radiation (breast/chest wall + axilla vs. none: OR [95% CI] = 3.723[2.271–6.104]), was an independent risk factor for lymphedema.

Conclusions

Preoperative obesity was an independent risk factor for BCRL in Chinese breast cancer survivors, and a preoperative BMI ≥ 25 kg/m2 indicated greater likelihood of lymphedema development within 6–18 months postoperatively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data are not available.

Abbreviations

BMI:

Body mass index

CI:

Confidence interval

BCRL:

Breast cancer-related lymphedema

ALND:

Axillary lymph-node dissection

SD:

Standard deviation

WHO:

World Health Organization

RLND:

Regional lymph node irradiation

References

  1. Taghian NR, Miller CL, Jammallo LS, Toole J, Skolny MN (2014) Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hemato 192:227–234

    Article  Google Scholar 

  2. Dayan JH, Ly CL, Kataru RP, Mehrara BJ (2018) Lymphedema: pathogenesis and novel therapies. Annu Rev Med 69:263–276

    Article  CAS  PubMed  Google Scholar 

  3. DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515

    Article  PubMed  Google Scholar 

  4. Chachaj A, Małyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudełko M et al (2010) Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 19:299–305

    Article  PubMed  Google Scholar 

  5. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26:3536–3542

    Article  PubMed  Google Scholar 

  6. Stolldorf DP, Dietrich MS, Ridner SH (2016) Symptom frequency, intensity, and distress in patients with lower limb lymphedema. Lymphat Res Biol 14:78–87

    Article  PubMed  PubMed Central  Google Scholar 

  7. Vassard D, Olsen MH, Zinckernagel L, Vibe-Petersen J, Dalton SO, Johansen C (2010) Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. Eur J Cancer 46:3211–3218

    Article  PubMed  Google Scholar 

  8. Khan F, Amatya B, Pallant JF, Rajapaksa I (2012) Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast 21:314–320

    Article  PubMed  Google Scholar 

  9. Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY et al (2018) The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer 25:309–314

    Article  PubMed  Google Scholar 

  10. Shaitelman SF, Chiang YJ, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV et al (2017) Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat 162:201–215

    Article  CAS  PubMed  Google Scholar 

  11. Ridner SH, Dietrich MS, Stewart BR, Armer JM (2011) Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 19:853–857

    Article  PubMed  PubMed Central  Google Scholar 

  12. Helyer LK, Varnic M, Le LW, Leong W, McCready D (2010) Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 16:48–54

    Article  PubMed  Google Scholar 

  13. Jammallo LS, Miller CL, Singer M, Horick NK, Skolny MN, Specht MC et al (2013) Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat 142:59–67

    Article  PubMed  Google Scholar 

  14. Leray H, Malloizel-Delaunay J, Lusque A, Chantalat E, Bouglon L, Chollet C et al (2020) Body mass index as a major risk factor for severe breast cancer-related lymphedema. Lymphat Res Biol 18:510–516

    Article  CAS  PubMed  Google Scholar 

  15. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315:2284–2291

    Article  CAS  PubMed  Google Scholar 

  16. Ma S, Xi B, Yang L, Sun J, Zhao M, Bovet P (2021) Trends in the prevalence of overweight, obesity, and abdominal obesity among Chinese adults between 1993 and 2015. Int J Obes (Lond) 45:427–437

    Article  PubMed  Google Scholar 

  17. Ancukiewicz M, Miller CL, Skolny MN, O’Toole J, Warren LE, Jammallo LS et al (2012) Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat 135:145–152

    Article  PubMed  PubMed Central  Google Scholar 

  18. Greene AK, Grant FD, Slavin SA (2012) Lower-extremity lymphedema and elevated body-mass index. N Engl J Med 366:2136–2137

    Article  CAS  PubMed  Google Scholar 

  19. Weitman ES, Aschen SZ, Farias-Eisner G, Albano N, Cuzzone DA, Ghanta S et al (2013) Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PLoS ONE 8:e70703

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Savetsky IL, Torrisi JS, Cuzzone DA, Ghanta S, Albano NJ, Gardenier JC et al (2014) Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema. Am J Physiol Heart Circ Physiol 307:H165–H172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Aschen S, Zampell JC, Elhadad S, Weitman E, De Brot AM, Mehrara BJ (2012) Regulation of adipogenesis by lymphatic fluid stasis: part II. Expression of adipose differentiation genes. Plast Reconstr Surg 129:838–847

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ghanta S, Cuzzone DA, Torrisi JS, Albano NJ, Joseph WJ, Savetsky IL et al (2015) Regulation of inflammation and fibrosis by macrophages in lymphedema. Am J Physiol Heart Circ Physiol 308:H1065–H1077

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. McLaughlin SA, Brunelle CL, Taghian A (2020) Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol 38:2341–2350

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ee C, Cave AE, Naidoo D, Bilinski K, Boyages J (2020) Weight before and after a diagnosis of breast cancer or ductal carcinoma in situ: a national Australian survey. BMC Cancer 20:113

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N et al (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26:3250–3259

    Article  PubMed  PubMed Central  Google Scholar 

  26. Roberts SA, Gillespie TC, Shui AM, Brunelle CL, Daniell KM, Locascio JJ et al (2021) Weight loss does not decrease risk of breast cancer-related arm lymphedema. Cancer 127:3939–3945

    Article  PubMed  Google Scholar 

  27. Tsai CL, Hsu C-Y, Chang WW, Lin Y-N (2020) Effects of weight reduction on the breast cancer-related lymphedema: a systematic review and meta-analysis. Breast 52:116–121

    Article  PubMed  PubMed Central  Google Scholar 

  28. Provan D (2019) Body weight and the management of lymphoedema. Br J Community Nurs 24:576–579

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Shaomei Shang and Ling Wang were responsible for the study design. Ning Liu and Miao Yu performed data collection. Hongbo Chen and Yuanzhen Li performed data analysis. Ling Wang, Hongbo Chen, Yuanzhen Li, and Huixue Wang were responsible for the drafting of the manuscript. Shaomei Shang made critical revision of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shaomei Shang.

Ethics declarations

Ethics approval

This study had appropriate ethical approval (the Peking University Research Ethics Committee, IRB00001052-21051).

Consent to participate

Written informed consent was obtained from the parents.

Consent for publication

No participants are identifiable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L., Chen, H., Li, Y. et al. Body mass index increases the risk of breast cancer-related lymphedema at 6–18 months after surgery: a retrospective study. Support Care Cancer 31, 278 (2023). https://doi.org/10.1007/s00520-023-07721-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-07721-7

Keywords

Navigation